Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Caixin Global
Caixin Global
Business
Caixin Automation

Shanghai Composite Index Fell 0.78% on Wednesday

China’s benchmark Shanghai Composite Index (000001.SH) lost 0.78% on Wednesday, while the Shenzhen Component Index (399001.SZ) fell 0.99%.

Shanghai’s tech-heavy STAR 50 Index (000688.SH) lost 1.64% for the day, while Shenzhen’s similar ChiNext Index (399006.SZ) fell 0.9%.

Below is a rundown of the top China business and finance stories, plus other news for the day:

· Hong Kong Regulator Confident in Streamlining of Cross-Border Transfer of Mainland Audit Paper

Accounting and Financial Reporting Council chair says procedure will be “greatly shortened” from 9-month average

· Another Regulatory Official Probed in China’s Sweeping Tobacco Industry Crackdown

Former department head under investigation for “serious violation of law and discipline”

· Fitness App Keep Raises $38.3 Million In Lackluster Hong Kong IPO

Valuation short nearly $400 million from latest funding round

· China Begins Campaign Against Illegal Reproductive Services

The six-month effort will target surrogacy, the illegal sale of sperm and eggs, and other illicit activities involving technology that helps people have children

· China Strengthens Rules for ‘Self’ Media, With Onus on Platforms to Vet Content

Websites must ensure that non-government, independent content providers clearly identify their sources when posting on current affairs

· China’s New Office for Hong Kong and Macao Affairs Has Its First Head

Xia Baolong chaired a meeting on Tuesday of the recently created body overseeing the two special administrative regions, according to a government statement

· Tech Insider: Ant Group Fined, Zeekr EVs Heading to Israel

Ant Group offers to buy back shares at big discount, China’s car sales slow in price war’s wake

· China’s Car Sales Slow as Price War Disrupts Market

Passenger vehicle sales may be slightly up from a year ago, but figures are still lower than the same period in 2021, new industry data shows

· Fosun Partners with Rongcan Biotech to Eye Alternatives to Develop mRNA Drugs

Sources say deal may be a failsafe if German BioNTech fails to receive approval for the Chinese mainland

· China’s Mutual Funds Slash Fees to Encourage Investor Participation

19 firms have cut fees on almost 1,600 products in response to new plan from regulators

Click here to read more of the latest news.

This article was generated by Caixin Automation.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.